Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Spectrum acquires full rights and intellectual property to Altair's RenaZorb in all fields

Aug. 11, 2009

Lilly discovers new MR antagonists for chronic kidney disease therapy

Aug. 11, 2009

Mirabegron does not affect PK, PD and safety profiles of metformin in healthy adults

Aug. 7, 2009

Kringle concludes dosing and safety evaluation in phase Ia trial of rhHGF in renal disease

Aug. 6, 2009

The European Commission approves Otsuka's Samsca

Aug. 5, 2009

Anti-inflammatory agent bindarit reduces MCP-1 excretion in patients with active lupus nephritis

July 28, 2009

Plethora enters evaluation and option agreement for PSD-503

July 20, 2009

Cytochroma initiates pharmacokinetic study of CTAP-101 in stage 3 or 4 CKD patients

July 17, 2009

Rituximab efficacy largely transient in pediatric steroid-dependent nephrotic syndrome

July 14, 2009

Tamsulosin associated with postoperative cataract surgery complications

July 14, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...